Article
PSMA expression on neovasculature of solid tumors.
1 Sept 2020
Abstract excerpt
The use of prostate specific membrane antigen (PSMA) binding agents, labelled with diagnostic and therapeutic radio-isotopes is opening the potential for a new era of personalized management of prostate carcinoma. A wide variety of immunohistochemistry studies have shown PSMA also to be upregulated on the endothelial cells of the neovasculature of a wide variety of other solid tumors where it may facilitate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
